Abstract
Renal cell cancer is an increasingly common tumor involving mostly adults. Surgical excision is the treatment of choice and recently surgical innovation has resulted in excellent outcomes for nephron-sparing surgery. Energy-based ablative procedures are being increasingly explored as an alternative to surgery to minimize morbidity. Radiation therapy has had relatively little role in the management of patients with renal cell cancer. Advances in the imaging, treatment planning, and treatment delivery has made radiation treatments safer now than ever before. In advanced renal cell cancer, radiation therapy can play a role in the management of extensive disease in patients with poor overall condition, adjuvant to surgical or other ablative procedures, and in patients with metastatic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amendola BE, Wolf AL, Coy SR, Amendola M, Bloch L. Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J. 2000;6:372–6.
Atkins MB, Avigan DE, Bukowski RM, Childs RW, Dutcher JP, Eisen TG, et al. Innovations and challenges in renal cancer. Clin Cancer Res. 2004;10(18):6277S–81S.
Badalament RA, Kreutzer E, Cluck RW, Herr HW, Wong GY, Fair WR, et al. Surgical treatment of brain metastases from renal cell carcinoma. Urology. 1990;36(2):112–7.
Beitler JJ, Makara D, Silverman P, Lederman G. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol. 2004;27:646–8.
Bratherton III D. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol. 1964;37(434):141.
Chakrabarty A, Hillman GG, Maughan RL, Ali E, Pontes JE, Haas GP. Radiation therapy enhances the therapeutic effect of immunotherapy on pulmonary metastases in a murine renal adenocarcinoma model. In Vivo. 1994;8:25–31.
Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7:151–60.
Chiou RK, Vessella RL, Limas C, Shafer RB, Elson MK, Arfman EW, et al. Monoclonal antibody–Âtargeted radiotherapy of renal cell carcinoma using a nude mouse model. Cancer. 1988;61(9):1766–75.
Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys. 1996;34:251–66.
Dezso B, Haas GP, Hamzavi F, Kim S, Montecillo EJ, Benson PD, et al. The mechanism of local tumor Âirradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res. 1996;2: 1543–52.
Finney R. The value of radiotherapy in the treatment of hypernephroma–a clinical trial. Br J Urol. 1973;45:258–69.
Flocks R, Kadesky M. Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J Urol. 1958;79:196–201.
Frydenberg M, Gunderson L, Hahn G, Fieck J, Zincke H. Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies. J Urol. 1994;152:15–21.
Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8:89–91.
Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2005;3:288–95.
Gez E, Libes M, Bar-Deroma R, Rubinov R, Stein M, Kuten A. Postoperative irradiation in localized renal cell carcinoma: the Rambam medical center experience. Tumori. 2002;88:500–2.
Goyal LK, Suh JH, Reddy CA, Barnett GH. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000;47:1007–12.
Halperin EC, Harisiadis L. The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer. 1983;51:614–7.
Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, Gao Y, Mai W, Furge K, Qian CN, Amato R, Butler EB, Teh BT, Teh BS. Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2009;73:288–95.
Ikushima H, Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:1389–93.
Juusela H, Malmio K, Alfthan O, Oravisto K. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol. 1977;11:277–81.
Kao GD, Malkowicz SB, Whittington R, D’Amico AV, Wein AJ. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Radiology. 1994;193:725–30.
Kim WH, Kim DG, Han JH, Paek SH, Chung HT, Park CK, Kim CY, Kim YH, Kim JW, Jung HW. Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival. Int J Radiat Oncol Biol Phys.. 2012;82:1749–55.
Kjaer M, Frederiksen PL, Engelholm S. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group. Int J Radiat Oncol Biol Phys. 1987;13:665–72.
Krengli M, Calvo FA, Terrone C, Haddock MG, Hannoun-Levi JM, Thariat J, et al. Genitourinary Âcancer. In: Gunderson L, editor. Intraoperative irradiation: techniques and results. New York: Humana Press; 2011. p. 459–79.
Lam JS, Shvarts O, Pantuck AJ. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol. 2004;45:692–705.
Leith JT, Cook S, Chougule P, Calabresi P, Wahlberg L, Lindquist C, et al. Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. Acta Neurochir Suppl. 1994;62:18–27.
Makarewicz R, Zarzycka M, Kulińska G, Windorbska W. The value of postoperative radiotherapy in advanced renal cell cancer. Neoplasma. 1998;45:380–3.
Master VA, Gottschalk AR, Kane C, Carroll PR. Management of isolated renal fossa recurrence Âfollowing radical nephrectomy. J Urol. 2005;174:473–7.
Michalski JM. Kidney, renal pelvis, and ureter. In: Perez C, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008.
Nias A. Radiobiological aspects of pre-operative irradiation. Br J Radiol. 1967;40:166–9.
Novick AC. Advances in the management of localized renal cell cancer. Can J Urol. 2000;7(2):960–6.
Onufrey V, Mohiuddin M. Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys. 1985;11:2007–9.
Otto U, Huland H, Baisch H, Klöppel G. Transplantation of human renal cell carcinoma into NMRI nu/nu mice. III. Effect of irradiation on tumor acceptance and tumor growth. J Urol. 1985;134:170–4.
Payne BR, Prasad D, Szeifert G, Steiner M, Steiner L. Gamma surgery for intracranial metastases from renal cell carcinoma. J Neurosurg. 2000;92:760–5.
Rabinovitch RA, Zelefsky MJ, Gaynor JJ, Fuks Z. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol. 1994;12: 206–12.
Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer. 1970;25:26–40.
Riches E. The place of irradiation. JAMA. 1968;204(3):230–1.
Riches E, Griffiths I, Thackray A. New growths of the kidney and ureter. Br J Urol. 1951;23:297–356.
Rost A, Brosig W. Preoperative irradiation of renal cell carcinoma. Urology. 1977;10:414–7.
Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003;98:342–9.
Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, et al. Simultaneous antiangiogenic therapy and single–fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int. 2011;108:673–8.
Stein M, Kuten A, Halpern J, Coachman NM, Cohen Y, Robinson E. The value of postoperative irradiation in renal cell cancer. Radiother Oncol. 1992;24: 41–4.
Syljuåsen RG, Belldegrun A, Tso CL, Withers HR, McBride WH. Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection. Radiat Res. 1997;148:443–8.
Tunio M, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol. 2010;21:1839–45.
van der Werf-Messing B. Carcinoma of the kidney. Cancer. 1973;32:1056–61.
van der Werf-Messing B, van der Heul RO, Ledeboer RC. Renal cell carcinoma trial. Strahlentherapie Sonderb. 1981;76:169–75.
Verma J, Mahajan A. The role of radiation therapy in renal cell carcinoma. In: Lara Jr PN, Jonasch E, Âeditors. Kidney cancer. Springer-Verlag; 2012. p. 163–170.
Walsh L, Stanfield JL, Cho LC, Chang C, Forster K, Kabbani W, et al. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol. 2006;50:795–800.
Wersäll PJ, Blomgren H, Lax I, Kälkner KM, Linder C, Lundell G, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005;77:88–95.
Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology. 1996;47:187–93.
Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the MD Anderson cancer center. Int J Radiat Oncol Biol Phys. 1997;37:753–9.
Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, et al. High-dose, single-Âfraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71:484–90.
Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, Mechalakos J, Zatcky J, Fuks Z, Yamada Y. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:1744–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
McKee, A., Mahadevan, A., Walsh, T. (2013). Role for Radiation Therapy in Renal Cancer. In: Libertino, J. (eds) Renal Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7236-0_21
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7236-0_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7235-3
Online ISBN: 978-1-4614-7236-0
eBook Packages: MedicineMedicine (R0)